Grow Your Wealth
with Mutual Funds
Iti Pharma And Healthcare Fund Regular-growth
Equity
Mid Cap
Very High Risk
Latest AUM
₹ 251.9 Cr.
NAV as on 03 aug, 2026
₹ 18.03
+20.58%
3 years annulised
This Fund
Fund Details
Fund Names
Iti Pharma And Healthcare Fund Regular-growth
Inception Date
08 Nov 2021
Lock In
No Lock-in
Risk
Principal at very high risk
Category Average Annual Returns
6.04
Portfolio Composition Analysis
Equity
96.78%
Cash
3.22%
Portfolio Updated on: 13 Jul, 2026
Sector Allocations
Equity
Healthcare
Materials
Industrials
Financial
Portfolio Updated on: 03 aug, 2026
Top 10 Holdings
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 14.25% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 13.34% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 13.34% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 12.73% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 12.40% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.96% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.96% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.80% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.12% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.91% |
Debt & Credit Risk Analysis
| Alpha | -3.99% |
| Beta | 0.99% |
| R2 | 0.97% |
| Sharpe Ratio | 0.75% |
| Standard Deviation | 16.40% |
| Sortino Ratio | 1.07% |
Returns Analysis
| Tenure | Absolute | Annualised | Category Average |
|---|---|---|---|
| 3 Months | 13.25% | NA | 6.12% |
| 6 Months | 20.55% | NA | 12.92% |
| 9 Months | 9.33% | NA | 4.47% |
| 1 Year | 10.10% | 10.10% | 6.04% |
| 2 Years | 14.25% | 6.89% | 24.93% |
| 3 Years | 64.93% | 18.15% | 25.71% |
Iti Pharma And Healthcare Fund Regular-growth is one Equity mutual fund offered by ITI Mutual Fund. Launched on 08 Nov 2021, the fund aims Capital appreciation over long term. Investments in equity and equity related securities of companies engaged in Pharma and Healthcare. Investors should consult their financial advisers if in doubt about whether the product is suitable for them. It manages assets worth ₹251.9 crore as on Tue Jun 30, 2026. The expense ratio stands at 2.63%.
Rajesh Bhatia has experience Prior to joining ITI Mutual Fund, he was associated with The Investment Trust Of India Ltd, Simto Investment Company Ltd, ProAlpha Systematic Capital, Heritage India Advisors Ltd and Reliance Capital Asset Management Ltd
Dhimant Shah has experience Prior to joining ITI Mutual Fund, he has worked with Principal Mutual Fund, HSBC AMC, Reliance Mutual Fund, ASK Raymond James Securities Pvt. Ltd. and IL&FS AMC. Senior Analyst from April 1997 to August 2003.
Rohan Korde has experience Prior to joining ITI Mutual Fund, he has worked with BOB Capital Markets as Vice President
Top Performing Mutual Funds
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Plan-growth | 4,997.7 | +2.81% | +17.48% | +25.25% | +20.07% | +24.60% | +17.98% |
| SBI Healthcare Opportunities Fund Direct Plan-idcw | 4,997.7 | +2.81% | +17.48% | +25.25% | +20.07% | +24.60% | +17.98% |
| SBI Healthcare Opportunities Fund-growth | 4,997.7 | +2.72% | +17.19% | +24.63% | +18.87% | +23.32% | +16.75% |
| SBI Healthcare Opportunities Fund-idcw | 4,997.7 | +2.72% | +17.19% | +24.63% | +18.87% | +23.32% | +16.75% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | 6,624.6 | +0.97% | +10.20% | +15.47% | +10.98% | +24.03% | +16.63% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | 6,624.6 | +0.97% | +10.20% | +15.47% | +10.98% | +24.03% | +16.63% |
| DSP Healthcare Fund Direct-growth | 3,514.0 | +2.43% | +13.63% | +18.99% | +10.81% | +21.00% | +15.99% |
| DSP Healthcare Fund Direct-idcw | 3,514.0 | +2.43% | +13.63% | +18.99% | +10.81% | +21.00% | +15.99% |
| Mirae Asset Healthcare Fund Direct-growth | 3,252.5 | +3.07% | +14.10% | +24.01% | +19.66% | +23.87% | +15.83% |
| Mirae Asset Healthcare Fund Direct-idcw | 3,252.5 | +3.07% | +14.10% | +24.01% | +19.66% | +23.87% | +15.83% |
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More Funds from ITI Mutual Fund
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| Iti Pharma And Healthcare Fund Direct-growth | 251.9 | +2.47% | +13.75% | +21.62% | +12.15% | +20.38% | — |
| Iti Pharma And Healthcare Fund Regular-idcw | 251.9 | +2.32% | +13.25% | +20.55% | +10.10% | +18.15% | — |
| Iti Pharma And Healthcare Fund Direct-idcw | 251.9 | +2.47% | +13.75% | +21.62% | +12.15% | +20.38% | — |
growth is based on 1-month returns of the funds
Top Mutual Funds
Top funds are based on Fund AUM
Top Equity Funds
| Fund name | ||||
|---|---|---|---|---|
| Sbi Healthcare Opportunities Fund Direct Plan-growth | ₹595.67 | +24.60% | +17.98% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-idcw | ₹413.85 | +24.60% | +17.98% | — |
| Sbi Healthcare Opportunities Fund-growth | ₹514.75 | +23.32% | +16.75% | — |
| Sbi Healthcare Opportunities Fund-idcw | ₹324.27 | +23.32% | +16.75% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | ₹47.77 | +24.03% | +16.63% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | ₹28.85 | +24.03% | +16.63% | — |
| Dsp Healthcare Fund Direct-growth | ₹49.33 | +21.00% | +15.99% | — |
| Dsp Healthcare Fund Direct-idcw | ₹28.53 | +21.00% | +15.99% | — |
| Mirae Asset Healthcare Fund Direct-growth | ₹51.65 | +23.87% | +15.83% | — |
| Mirae Asset Healthcare Fund Direct-idcw | ₹31.11 | +23.87% | +15.83% | — |
growth is based on 5Y returns of the funds
Historical NAV
| Date | NAV |
|---|---|
| 03 Aug 2026 | ₹18.03 |
| 31 Jul 2026 | ₹17.94 |
| 30 Jul 2026 | ₹17.90 |
| 29 Jul 2026 | ₹17.93 |
| 28 Jul 2026 | ₹17.71 |
| 27 Jul 2026 | ₹17.70 |
| 24 Jul 2026 | ₹17.42 |
| 23 Jul 2026 | ₹17.46 |
| 22 Jul 2026 | ₹17.54 |
| 21 Jul 2026 | ₹17.73 |
| 20 Jul 2026 | ₹17.68 |
| 17 Jul 2026 | ₹17.45 |
| 16 Jul 2026 | ₹17.66 |
| 15 Jul 2026 | ₹17.66 |
| 14 Jul 2026 | ₹17.60 |
| 13 Jul 2026 | ₹17.50 |
| 10 Jul 2026 | ₹17.55 |
| 09 Jul 2026 | ₹17.50 |
| 08 Jul 2026 | ₹17.27 |
| 07 Jul 2026 | ₹17.48 |
| 06 Jul 2026 | ₹17.63 |
| 03 Jul 2026 | ₹17.62 |
| 02 Jul 2026 | ₹17.38 |
| 01 Jul 2026 | ₹17.27 |
| 30 Jun 2026 | ₹17.34 |
| 29 Jun 2026 | ₹17.25 |
| 25 Jun 2026 | ₹17.13 |
| 24 Jun 2026 | ₹17.14 |
| 23 Jun 2026 | ₹17.12 |
| 22 Jun 2026 | ₹16.96 |
Portfolio Updated on: 04 Aug, 2026
Fund Growth & Size Analysis
+₹251.9 Cr
Since Launch
This Fund
Category Average
Compare Mutual funds
Iti Pharma And Healthcare Fund Regular-growth Returns Comparison
Compare Iti Pharma And Healthcare Fund Regular-growth with any MF,
EYF, stock or index
Jan 1, 2026 – Feb 1, 2026
Iti Pharma And Healthc....
No funds found for your search.
Iti Pharma And Healthcare Fund Regular-growth FAQ'S
- Sharpe Ratio: 0.75%
- Standard Deviation: 16.40%
- Beta: 0.99%
- Alpha: -3.99%
- R-squared: 0.97%
- Information Ratio: -1.42%
- Sortino Ratio: 1.07%
Additional important ratios:
As of Tue Jun 30, 2026, the total assets managed under Iti Pharma And Healthcare Fund Regular-growth stand at approximately ₹ 251.9 crore.
The Iti Pharma And Healthcare Fund Regular-growth has delivered the following short-term performance:
- 3 Months Return: 13.25%
- 6 Months Return: 20.55%
The historical growth of the Iti Pharma And Healthcare Fund Regular-growth is reflected through its CAGR returns:
- 3 Year CAGR: 18.15%
- Return Since Launch: 13.25%
The portfolio of Iti Pharma And Healthcare Fund Regular-growth is distributed across different asset classes as follows:
- Equity: 96.78%
- Other Assets: 3.22%
The Iti Pharma And Healthcare Fund Regular-growth is managed by Rohan Korde, representing ITI Mutual Fund.
The Iti Pharma And Healthcare Fund Regular-growth investments are allocated across market caps in the following manner:
- Large Cap Stocks: 36.69%
- Mid Cap Stocks: 43.49%
- Small Cap Stocks: 19.82%
Top stock holdings of Iti Pharma And Healthcare Fund Regular-growth include:
- Sun Pharmaceutical Industries Ltd – represents 14.25% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 13.34% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 13.34% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 12.73% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 12.40% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 10.96% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 10.96% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.80% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.12% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 10.91% of the portfolio
Major sector exposures in Iti Pharma And Healthcare Fund Regular-growth are:
- Healthcare – accounts for 1,173.18% of the portfolio
- Materials – accounts for 43.61% of the portfolio
- Industrials – accounts for 14.41% of the portfolio
- Financial – accounts for 14.03% of the portfolio
